The antitumorigenic trifecta.
Publication
, Journal Article
Mowery, YM; Pizzo, SV
Published in: Blood
August 27, 2009
The laboratory of Judah Folkman identified the potent endogenous antiangiogenic protein angiostatin in 1994.(1) In this issue of Blood, Lee and colleagues propose 2 new mechanisms of action for angiostatin that may represent promising targets for new cancer therapeutics.(2).
Published In
Blood
DOI
EISSN
1528-0020
Publication Date
August 27, 2009
Volume
114
Issue
9
Start / End Page
1727 / 1728
Location
United States
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Mowery, Y. M., & Pizzo, S. V. (2009). The antitumorigenic trifecta. Blood, 114(9), 1727–1728. https://doi.org/10.1182/blood-2009-06-226233
Mowery, Yvonne M., and Salvatore V. Pizzo. “The antitumorigenic trifecta.” Blood 114, no. 9 (August 27, 2009): 1727–28. https://doi.org/10.1182/blood-2009-06-226233.
Mowery YM, Pizzo SV. The antitumorigenic trifecta. Blood. 2009 Aug 27;114(9):1727–8.
Mowery, Yvonne M., and Salvatore V. Pizzo. “The antitumorigenic trifecta.” Blood, vol. 114, no. 9, Aug. 2009, pp. 1727–28. Pubmed, doi:10.1182/blood-2009-06-226233.
Mowery YM, Pizzo SV. The antitumorigenic trifecta. Blood. 2009 Aug 27;114(9):1727–1728.
Published In
Blood
DOI
EISSN
1528-0020
Publication Date
August 27, 2009
Volume
114
Issue
9
Start / End Page
1727 / 1728
Location
United States
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology